NO171016C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivaterInfo
- Publication number
- NO171016C NO171016C NO884599A NO884599A NO171016C NO 171016 C NO171016 C NO 171016C NO 884599 A NO884599 A NO 884599A NO 884599 A NO884599 A NO 884599A NO 171016 C NO171016 C NO 171016C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- quinoline derivatives
- therapeutic active
- analogy procedure
- active quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26244187 | 1987-10-16 | ||
JP10884088 | 1988-04-30 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO884599D0 NO884599D0 (no) | 1988-10-14 |
NO884599L NO884599L (no) | 1989-04-17 |
NO171016B NO171016B (no) | 1992-10-05 |
NO171016C true NO171016C (no) | 1993-01-13 |
Family
ID=26448650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO884599A NO171016C (no) | 1987-10-16 | 1988-10-14 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater |
Country Status (16)
Country | Link |
---|---|
US (1) | US5013841A (no) |
EP (1) | EP0312085B1 (no) |
KR (1) | KR930006774B1 (no) |
CN (1) | CN1021967C (no) |
DE (1) | DE3880953T2 (no) |
DK (1) | DK573788A (no) |
ES (1) | ES2054762T3 (no) |
FI (1) | FI884752A (no) |
HU (1) | HU204521B (no) |
IL (1) | IL88003A (no) |
NO (1) | NO171016C (no) |
NZ (1) | NZ226574A (no) |
PH (1) | PH25530A (no) |
PT (1) | PT88769A (no) |
RU (2) | RU1780534C (no) |
YU (3) | YU46647B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
US5262417A (en) * | 1988-12-06 | 1993-11-16 | The Upjohn Company | Antibacterial quinolone compounds |
JPH05506033A (ja) | 1990-04-18 | 1993-09-02 | ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド | 抗微生物性キノロニルラクタム類 |
DE4019023A1 (de) * | 1990-06-14 | 1991-12-19 | Bayer Ag | Verfahren zur herstellung von chinolincarbonsaeuren |
TW252107B (no) * | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
FR2916446B1 (fr) * | 2007-05-24 | 2009-08-21 | Biocodex Sa | Nouveau procede de synthese de fluoroquinolones |
CA3087898A1 (en) | 2018-02-02 | 2019-08-08 | Ripple Therapeutics Corporation | Glass formulations comprising steroid dimers and uses thereof |
CA3176134A1 (en) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3142854A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
DE3248506A1 (de) * | 1982-12-29 | 1984-07-05 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
DE3542002A1 (de) * | 1985-11-28 | 1987-06-04 | Bayer Ag | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
US4668680A (en) * | 1985-12-12 | 1987-05-26 | Warner-Lambert Company | 5-amino-6,8-difluoroquinolones as antibacterial agents |
JPS62215572A (ja) * | 1986-03-17 | 1987-09-22 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
DE3711193A1 (de) * | 1987-04-02 | 1988-10-13 | Bayer Ag | 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-10-11 IL IL88003A patent/IL88003A/xx unknown
- 1988-10-14 PT PT88769A patent/PT88769A/pt unknown
- 1988-10-14 NZ NZ226574A patent/NZ226574A/en unknown
- 1988-10-14 DK DK573788A patent/DK573788A/da not_active Application Discontinuation
- 1988-10-14 YU YU192288A patent/YU46647B/sh unknown
- 1988-10-14 EP EP88117113A patent/EP0312085B1/en not_active Expired - Lifetime
- 1988-10-14 FI FI884752A patent/FI884752A/fi not_active Application Discontinuation
- 1988-10-14 NO NO884599A patent/NO171016C/no unknown
- 1988-10-14 ES ES88117113T patent/ES2054762T3/es not_active Expired - Lifetime
- 1988-10-14 HU HU885296A patent/HU204521B/hu not_active IP Right Cessation
- 1988-10-14 PH PH37684A patent/PH25530A/en unknown
- 1988-10-14 DE DE88117113T patent/DE3880953T2/de not_active Expired - Fee Related
- 1988-10-15 CN CN88108434A patent/CN1021967C/zh not_active Expired - Fee Related
- 1988-10-15 KR KR1019880013470A patent/KR930006774B1/ko active IP Right Grant
-
1989
- 1989-08-04 US US07/389,900 patent/US5013841A/en not_active Expired - Fee Related
- 1989-10-13 YU YU198989A patent/YU46684B/sh unknown
- 1989-10-13 YU YU199089A patent/YU46703B/sh unknown
- 1989-10-18 RU SU894742183A patent/RU1780534C/ru active
- 1989-10-20 RU SU894742186A patent/RU1830067C/ru active
Also Published As
Publication number | Publication date |
---|---|
YU198989A (en) | 1990-04-30 |
FI884752A (fi) | 1989-04-17 |
DK573788D0 (da) | 1988-10-14 |
RU1780534C (ru) | 1992-12-07 |
ES2054762T3 (es) | 1994-08-16 |
RU1830067C (ru) | 1993-07-23 |
DE3880953T2 (de) | 1993-10-14 |
YU46647B (sh) | 1994-01-20 |
NO884599L (no) | 1989-04-17 |
IL88003A (en) | 1992-11-15 |
NZ226574A (en) | 1991-07-26 |
CN1033996A (zh) | 1989-07-19 |
YU46684B (sh) | 1994-04-05 |
HUT49342A (en) | 1989-09-28 |
YU46703B (sh) | 1994-04-05 |
PT88769A (pt) | 1989-07-31 |
NO171016B (no) | 1992-10-05 |
IL88003A0 (en) | 1989-06-30 |
YU192288A (en) | 1990-04-30 |
NO884599D0 (no) | 1988-10-14 |
EP0312085A3 (en) | 1990-05-30 |
US5013841A (en) | 1991-05-07 |
CN1021967C (zh) | 1993-09-01 |
AU619214B2 (en) | 1992-01-23 |
DE3880953D1 (de) | 1993-06-17 |
AU2375488A (en) | 1989-04-20 |
KR890006620A (ko) | 1989-06-14 |
YU199089A (en) | 1990-04-30 |
FI884752A0 (fi) | 1988-10-14 |
PH25530A (en) | 1991-07-24 |
KR930006774B1 (ko) | 1993-07-23 |
EP0312085B1 (en) | 1993-05-12 |
DK573788A (da) | 1989-04-17 |
HU204521B (en) | 1992-01-28 |
EP0312085A2 (en) | 1989-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO171506C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater | |
NO170726C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolinderivater | |
NO171638C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater | |
NO170483C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater | |
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO171788C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fosfinsyrederivater | |
NO170727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
NO820479L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater | |
NO169014C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater | |
NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
NO171507C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater | |
NO172489C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
NO170021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater | |
NO168037C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater. | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater |